biopharmaceutical


Also found in: Dictionary, Wikipedia.
Related to biopharmaceutical: biotechnology

biopharmaceutical

(bī′ō-fär′mə-so͞o′tĭ-kəl)
n.
A drug produced by means of biotechnology, consisting of a large, complex molecule such as a protein rather than a small molecule.
adj.
1. Of or relating to a drug or drugs produced by means of biotechnology: the biopharmaceutical industry.
2. Of or relating to properties of pharmaceutical preparations and their effects after administration: biopharmaceutical factors affecting intestinal absorption of the drug.

biopharmaceutical

A generic term for a biomolecule (e.g., proteins), including antibodies and nucleic acids and antisense oligonucleotides, which are produced in a transgenic organism—e.g., mice, livestock, fish, or plant—and used as a therapeutic agent.
References in periodicals archive ?
The report is designed to help professionals in the global biopharmaceutical industry better understand the current development states, technical capabilities and relative competencies of China and India in biologic drug R&D and manufacturing, as well as the future growth potentials of their biopharmaceutical industries.
In 2008, the market size of China's biopharmaceutical industry was about 70 billion Yuan (about 10 billion US Dollars), where the growth rate passed the whole market size of China's medicine market and also above three sub-sectors including chemical medicine materials, chemical medicine dose and traditional Chinese prepared medicines.
During the past five years, estimates for biopharmaceuticals have varied widely as analysts and producers have juggled the promise of new drugs with the technological and financial risks of manufacturing them efficiently.
GBI Research, the leading business intelligence provider has released its latest research report, Biopharmaceutical Manufacturing in India, China and South Korea Regulatory Framework, Infrastructure Support and Discovery Funding Create an Environment Conducive to Growth.
William Downey, President of HighTech Business Decisions, explains, "We extensively interviewed 41 directors of biomanufacturing at pharmaceutical and biotechnology companies worldwide, and 27 biopharmaceutical contract manufacturers.
is a biopharmaceutical company focused on the development of late-stage "disruptive" clinical products, especially for already-approved drugs in new formulations and/or new indications that are patent-protected and which represent new therapeutics with greater clinical and economic value.
On the other hand, high capital and operational cost impede the growth of the membrane technology market in pharmaceutical, biopharmaceutical and life sciences industries.
Morria Biopharmaceuticals Plc is a biopharmaceutical company focusing on the development of anti-inflammatory agents termed Multi-Functional Anti-Inflammatory Drugs (MFAID).
MLS's contract biopharmaceutical manufacturing facility produces proteins and other biologicals for biopharmaceutical and biotechnology companies engaged in research for new drugs and vaccines.
We believe that our broad range of in-house capabilities provides a development and commercialization platform on which to bring new biopharmaceuticals and medical device products to market.